Cipla
Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world
July 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan
The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …
Cipla halts HIV drug production due to delayed government funding
March 6, 2017Sales and Marketing Cipla, HIV, India, Lopinavir
Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …
India’s NPPA identifies 634 non-compliant drug pricings
February 24, 2017Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa
India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …
Ireena Vittal joins Cipla executive board
November 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment
Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …
Cipla receives FDA approval for generic version of Valeant antidepressant
August 30, 2016Manufacturing and Production, Sales and Marketing Cipla, FDA, Valeant, Wellbutrin
Indian multinational pharma and biotech company Cipla has announced that its US arm InvaGen Pharmaceuticals has received approval from the …
India-based Cipla gets new chief financial officer
June 8, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Dr Reddy's, cfo, dr reddys
Cipla (NSE: CIPLA) has poached a top executive from Dr. Reddy’s by naming Kedar Upadhye as its new global chief …
Gilead and Strides partner in HIV
January 21, 2015Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf
Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …
New chief executive for Cipla
November 30, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena
Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …
Pharma manufacturing news in brief
August 14, 2012Manufacturing and Production Advanced Bioscience, Almac, Amneal, Cipla, Isis, Sanofi Pasteur
Cipla opening three new API plants as Indian trade delegations forges closer ties with Sri Lanka; plus facility updates from …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
